Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair

被引:35
作者
Chen, ZY
Felsheim, R
Wong, P
Augustin, LB
Metz, R
Kren, BT
Steer, CJ
机构
[1] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA
[3] ValiGen Inc, Newtown, PA 18940 USA
关键词
allele-specific PCR; cell-free bacterial assay; gene therapy; mismatch repair; mitochondria; nuclear extract; plasmid; RNA/DNA oligonucleotide; site-directed conversion; single-point mutation;
D O I
10.1006/bbrc.2001.5156
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chimeric RNA/DNA oligonucleotides (ONs) have been used successfully for site-specific modifications of episomal and chromosomal DNA in eukaryotic cells. We explored the possibility of applying this technique to mitochondrial DNA, as single-nucleotide defects in this genome are associated with a series of human diseases. Therefore, we determined whether mitochondria possess the enzymatic machinery for chimeric ON-mediated DNA alterations. We utilized an in vitro DNA repair assay and an Escherichia coli readout system with mutagenized plasmids carrying point mutations in antibiotic resistance genes. RNA/DNA ONs were designed to correct the defects and restore kanamycin and tetracyclin resistance. Using this system, we demonstrated that extracts from highly purified rat liver mitochondria possess the essential enzymatic activity to mediate precise single-nucleotide changes. Interestingly, the frequency of gene conversion was similar in both mitochondrial and nuclear extracts, as well as from quiescent and regenerating liver. The results indicate that mitochondria contain the machinery required for repair of genomic single-point mutations, and suggest that RNA/DNA ONs may provide a novel approach to the treatment of certain mitochondrial-based diseases. (C) 2001 Academic Press.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 32 条
[1]   Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide [J].
Alexeev, V ;
Igoucheva, O ;
Domashenko, A ;
Cotsarelis, G ;
Yoon, K .
NATURE BIOTECHNOLOGY, 2000, 18 (01) :43-47
[2]   In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide [J].
Bartlett, RJ ;
Stockinger, S ;
Denis, MM ;
Bartlett, WT ;
Inverardi, L ;
Le, TT ;
Man, NT ;
Morris, GE ;
Bogan, DJ ;
Metcalf-Bogan, J ;
Kornegay, JN .
NATURE BIOTECHNOLOGY, 2000, 18 (06) :615-622
[3]   Repair of mtDNA in vertebrates [J].
Bogenhagen, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1276-1281
[4]  
CHI NW, 1994, J BIOL CHEM, V269, P29984
[5]   Peptide nucleic acid delivery to human mitochondria [J].
Chinnery, PF ;
Taylor, RW ;
Diekert, K ;
Lill, R ;
Turnbull, DM ;
Lightowlers, RN .
GENE THERAPY, 1999, 6 (12) :1919-1928
[6]   Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes [J].
Clark, AB ;
Valle, F ;
Drotschmann, K ;
Gary, RK ;
Kunkel, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36498-36501
[7]   Mammalian mitochondrial extracts possess DNA end-binding activity [J].
Coffey, G ;
Lakshmipathy, U ;
Campbell, C .
NUCLEIC ACIDS RESEARCH, 1999, 27 (16) :3348-3354
[8]   Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract [J].
Cole-Strauss, A ;
Gamper, H ;
Holloman, WK ;
Muñoz, M ;
Cheng, N ;
Kmiec, EB .
NUCLEIC ACIDS RESEARCH, 1999, 27 (05) :1323-1330
[9]   Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide [J].
ColeStrauss, A ;
Yoon, KG ;
Xiang, YF ;
Byrne, BC ;
Rice, MC ;
Gryn, J ;
Holloman, WK ;
Kmiec, EB .
SCIENCE, 1996, 273 (5280) :1386-1389
[10]  
DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042